Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Earnings

Concrete Pumping Holdings Faces Critical Q3 Earnings Test

Robert Sasse by Robert Sasse
September 2, 2025
in Earnings, Industrial
0
Concrete Pumping Stock
0
SHARES
266
VIEWS
Share on FacebookShare on Twitter

Shares of Concrete Pumping Holdings are experiencing downward pressure ahead of the company’s pivotal third-quarter earnings release. The stock declined 1.6 percent to $6.96 in yesterday’s session, extending Friday’s 1.56 percent drop. This recent weakness reflects mounting investor apprehension as the company prepares to announce results after market close this Thursday.

Elevated Stakes Following Previous Shortfalls

Market experts anticipate earnings per share of $0.06 on revenue approximating $99.8 million for the third quarter. These expectations come with heightened significance following the company’s substantial miss last quarter. Concrete Pumping reported a loss of $0.01 per share compared to projected earnings of $0.03, while revenue of $94 million fell short of the $99 million consensus estimate.

CEO Bruce Young and CFO Iain Humphries will host a conference call at 23:00 MET on Thursday to present the quarterly performance and address analyst inquiries.

Revised Outlook Under Scrutiny

The company previously adjusted its full-year guidance downward in March, now projecting revenue between $400 million and $420 million. Management anticipates adjusted EBITDA in the range of $105 million to $115 million, with free cash flow expected to reach approximately $60 million.

Should investors sell immediately? Or is it worth buying Concrete Pumping?

Recent operational challenges have raised concerns among investors. The U.S. pumping segment experienced declining first-quarter revenue attributed to softening commercial construction activity. Restrictive monetary policy and unfavorable weather conditions have compounded these headwinds.

Contrasting Performance Narratives

Despite current pressures, Concrete Pumping Holdings has demonstrated notable achievements throughout 2025. The successful placement of $425 million in Senior Secured Notes, coupled with a special dividend distribution of $1.00 per share, previously propelled the stock upward by 27.6 percent.

Current valuation metrics present a more cautious picture. At $6.96 per share, the equity trades above the average analyst price target of $6.75. The predominant “Hold” rating among market observers indicates substantial skepticism regarding near-term performance.

This Thursday’s earnings release will prove decisive in determining whether Concrete Pumping Holdings can surpass expectations or whether the current negative momentum will continue.

Ad

Concrete Pumping Stock: Buy or Sell?! New Concrete Pumping Analysis from February 7 delivers the answer:

The latest Concrete Pumping figures speak for themselves: Urgent action needed for Concrete Pumping investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Concrete Pumping: Buy or sell? Read more here...

Tags: Concrete Pumping
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026
Myers Industries Stock
Analysis

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock
Cyber Security

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026
Next Post
Redwire Stock

Redwire's Financial Paradox: Record Contracts Amid Steep Losses

Glacier Stock

Glacier Bancorp Emerges as Regional Banking Standout

Amylyx Pharmaceuticals Stock

Amylyx Pharmaceuticals Faces Existential Crisis After Clinical Setbacks

Recommended

Super Micro Computer Stock

Super Micro Stock Surges Amid AI Infrastructure Boom

4 months ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

4 months ago
IBM Stock

Strong IBM Earnings Fail to Impress Market as Key Segment Shows Weakness

4 months ago
Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Trending

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

by Rodolfo Hanigan
February 7, 2026
0

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business...

CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes
  • Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com